Abound Bio, Inc

Imagine Pharma is a biotech company based in Pittsburgh, PA, dedicated to developing revolutionary treatments that improve patient outcomes. With a focus on three distinct platforms - Oral Delivery, Therapeutics, and Regenerative Medicine - Imagine Pharma is at the forefront of scientific exploration, developing first-in-class innovative therapies across multiple disease states. Driven by a deep understanding of human biology and a targeted scientific approach, Imagine Pharma is creating a pipeline of advancements that aim to make injections a thing of the past, cure diabetes, and accelerate wound healing. Through their cutting-edge research and development, Imagine Pharma is committed to delivering better patient experiences and outcomes.Generated from the website

MS2 Array LLC is a technology-enabled assay services company based in Pittsburgh, PA, specializing in the drug discovery industry. By leveraging fluorous partitioning and high-throughput mass spectrometry, the company delivers enhanced primary screening information that significantly reduces the need for secondary screening activities. This innovative approach results in improved quality hit sets, accelerating the progress of drug development projects. MS2 Array is dedicated to providing solutions that optimize the drug discovery process for its clients. Generated from the website

Vivasc Therapeutics Inc., based in Pittsburgh, PA, specializes in innovative drug delivery systems focused on reversing the effects of heart failure and treating atrial fibrillation. Utilizing their proprietary Cardiac Targeting Peptide, they aim to deliver therapeutic agents specifically to cardiomyocytes, addressing underlying cellular dysfunction rather than merely alleviating symptoms associated with heart diseases. Founded in 2020, the company has engaged in several STTR Phase I projects, demonstrating significant advancements in delivery methods for treatment options like miRNA and amiodarone, designed to target heart tissues with precision. Their research holds promise for improving patient outcomes by mitigating adverse effects commonly related to current heart failure and arrhythmia treatments. Generated from the website